Critical care of the liver transplant patient: An update

Current Opinion in Critical Care

Volumn 8, Issue 2, 2002, Pages 178-182

  McGilvray, Ian D ^a   Greig, Paul D ^a,b  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CYCLOSPORIN; DOPAMINE; METHYLENE BLUE; PROSTACYCLIN; PROSTAGLANDIN; TACROLIMUS; TERLIPRESSIN;

ARTIFICIAL VENTILATION; BACTERIAL PERITONITIS; CARDIOMYOPATHY; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DISEASE SEVERITY; HEMODYNAMIC MONITORING; HEPATOPULMONARY SYNDROME; HEPATORENAL SYNDROME; HUMAN; INTENSIVE CARE; LIVER CIRRHOSIS; LIVER DISEASE; LIVER GRAFT; LIVER TRANSPLANTATION; LIVING DONOR; LUNG EDEMA; NONHUMAN; PORTAL HYPERTENSION; POSITIVE END EXPIRATORY PRESSURE; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PULMONARY HYPERTENSION; REVIEW;

CRITICAL CARE; HEART TRANSPLANTATION; HEMODYNAMIC PROCESSES; HEPATOPULMONARY SYNDROME; HEPATORENAL SYNDROME; HUMANS; HYPERTENSION, PORTAL; HYPERTENSION, PULMONARY; LIVER DISEASES; LIVER TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; PULMONARY EDEMA; RESPIRATION, ARTIFICIAL;

EID: 0036968252     PISSN: 10705295     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075198-200204000-00015     Document Type: Review

References (23)

1. Lowell JA, Shaw BW: Critical care of liver transplant recipients. In Transplantation of the Liver. Edited by Maddrey WC, Schiff ER, Sorrell MF. Philadelphia: Lippincott Williams and Wilkins; 2001:385-404. A thorough overview of critical care topics and their relation to the liver transplant patient, of particular value for a useful classification of disease severity in this patient population.
2. Levy MF, Greene L, Ramsay MAE, et al.: Readmission to the intensive care unit after liver transplantation. Crit Care Med 2001, 29:18-24. • This retrospective study convincingly argues for a careful approach to the fluid management of the liver transplant patient.
3. Cardenas A, Uriz J, Gines P, et al.: Hepatorenal syndrome. Liver Transplant 2000, 6(suppl 1):S63-S71.
4. Sort P, Navasa M, Arroyo V, et al.: Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999, 341:403-409.
5. Brensing KA, Textor J, Perz J, et al.: Long term outcome after transjugular intrahepatic portosystemic shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study. Gut 2000, 47:288-295.
6. Mulkay JP, Louis H, Donckier V, et al.: Long-term terlipressin administration improves renal function in cirrhotic patientss with type 1 hepatorenal syndrome: a pilot study. Acta Gastroenterol Belg 2001, 64:15-19. • An interesting study that supports the notion that splanchnic vasodilation is central to the pathogenesis of renal dysfunction in the patient with portal hypertension.
7. Kuo PC, Plotkin JS, Gaine S, et al.: Portopulmonary hypertension and the liver transplant candidate. Transplantation 1999, 67:1087-1093.
8. Fallon MB: Methylene blue and cirrhosis: pathophysiologic insights, therapeutic dilemmas. Ann Int Med 2000, 133:738-740.
9. Schenk P, Madl C, Rezaie-Majd S, et al.: Methylene blue improves the hepa topulmonary syndrome. Ann Int Med 2000, 133:701-706. •• Although the benefits to patients with hepatopulmonary syndrome given methylene blue are variable, this work suggests a novel approach that might be useful in the acute management of a critically ill patient with hepatopulmonary syndrome.
10. Krowka MJ: Hepatopulmonary syndrome and extrahepatic vascular abnor malities. Liver Transplant 2001, 7:656-657.
11. Trotter JF, Box T, Heneghan M, et al.: Hepatopulmonary syndrome in transplant centers at different altitudes. Lancet 2001, 358:336.
12. Tan HP, Markowitz JS, Montgomery RA, et al.: Liver transplantation in patients with severe portopulmonary hypertension treated with preoperative chronic intravenous epoprostenol. Liver Transplant 2001, 7:745-749.
13. Krowka MJ, Frantz RP, McGoon MD, et al.: Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): a study of 15 patients with moderate to severe portopulmonary hypertension. Hepatology 1999, 30:641-648.
14. Jounieaux V, Leleu O, Mayeux I: Cardiopulmonary effects of nitric oxide inhalation and methylene blue injection in hepatopulmonary syndrome. Int Care Med 2001, 27:1103-1104.
15. Antonelli M, Conti G, Bufi M, et al.: Noninvasive ventilation for treatment of acute respiratory failure in patients undergoing solid organ transplantation. JAMA 2000, 283:235-241.
16. Yost CS, Matthay MA, Gropper MA: Etiology of acute pulmonary edema during liver transplantation: a series of cases with analysis of the edema fluid. Chest 2001, 119:219-223. • A brief but well-constructed description of one mechanism underlying perioperative pulmonary edema in the liver transplant patient.
17. Valeriano V, Funaro S, Lionetti R, et al.: Modification of cardiac function in cirrhotic patients with and without ascites. Am J Gastroenterol 2000, 95:3200-3205.
18. Myers RP, Lee SS: Cirrhotic cardiomyopathy and liver transplantation. Liver Transplant 2000, 6(suppl 1):S44-S52.
19. Plotkin JS, Johnson LB, Rustgi V, et al.: Coronary artery disease and liver transplantation: the state of the art. Liver Transplant 2000, 6(suppl 1):S53-S56.
20. Eckhoff DE, Frenette L, Sellers MT, et al.: Combined cardiac surgery and liver transplantation. Liver Transplantation 2001, 7:60-61.
21. Bak T, Wachs M, Trotter J, et al.: Adult-to-adult living donor liver transplantation using right lobe grafts: results and lessons learned from a single-centerexperience. Liver Transplant 2001, 7:680-686.
22. Ayata G, Pomfret E, Pomposelli JJ, et al.: Adult-to-adult live donor liver transplantation: a short-term clinicopathologic study. Hum Pathol 2001, 32:814-822.
23. Miller CM, Gondolesi GE, Florman S, et al.: One hundred nine living donor liver transplants in adults and children: a single-center experience. Ann Surg 2001, 234:301-312. •• A well-written report, and the largest published series to date of right lobe living donor liver transplantations performed in North America. Technical issues are thoughtfully addressed.